Status:
UNKNOWN
Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage
Lead Sponsor:
RenJi Hospital
Collaborating Sponsors:
National Natural Science Foundation of China
Conditions:
Renal Cell Carcinoma
Zero Ischemia
Eligibility:
All Genders
15-80 years
Phase:
NA
Brief Summary
To evaluate the feasibility and efficiency of zero ischemia laparoscopic radio frequency ablation assisted enucleation of T1a renal cell carcinoma in comparison with the conventional laparoscopic parti...
Detailed Description
Warm ischemic injury is one of the most important factors affecting renal function in partial nephrectomy (PN). Zero ischemia partial nephrectomy technique using renal arterial branch microdissection ...
Eligibility Criteria
Inclusion
- patients with sporadic, unilateral, newly diagnosed T1a presumed renal cell carcinoma
- patients with normal contralateral renal function (differential renal function of \>40% as determined by radionuclide scintigraphy)
- patients agreeable to participate in this long-term follow-up study
Exclusion
- patients' aged \>80 years
- patients with other renal diseases
- patients not able to tolerate the laparoscopic procedure
- patients with previous renal surgery or history of any inflammatory conditions of the operative kidney
- patients with the renal tumor close to the calyces
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2014
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01838720
Start Date
April 1 2013
End Date
October 1 2014
Last Update
August 13 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
RenJi Hospital
Shanghai, Shanghai Municipality, China, 200127